Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
GYRE
INMD
Add up to 3 more stocks
GYRE
Gyre Therapeutics, Inc.
-4.15%
$7.04-0.30Delayed quote: Oct 6, 2026, 10:50 AM EDT
Market Cap
$785.44M
52W Range
$5.44 - $9.42
INMD
InMode Ltd.
-0.81%
$14.02-0.12Delayed quote: Oct 6, 2026, 10:50 AM EDT
Market Cap
$805.59M
52W Range
$12.72 - $16.74
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 11.39 |
| Forward P/E | N/A | 10.81 |
| PEG Ratio | N/A | 1.15 |
| P/B Ratio | 7.28 | 1.28 |
| P/S Ratio | 6.58 | 2.15 |
| P/FCF Ratio | N/A | 9.21 |
| EV/EBITDA | N/A | 5.92 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 94.3% | 76.5% |
| Operating Margin | 9.9% | 18.5% |
| Net Margin | -14.5% | 20.7% |
| ROE | -13.3% | 12.3% |
| ROA | -8.7% | 10.8% |
| ROIC | -9.8% | 9.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 4.26 | 8.18 |
| Quick Ratio | 3.86 | 7.28 |
| Debt/Equity | 0.03 | 0.01 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.